Advertisement

Topics

Celladon Corporation Company Profile

06:47 EDT 30th April 2017 | BioPortfolio

Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in developing molecular therapies for the treatment of heart failure. The company’s products target the key enzyme deficiency in advanced heart failure, SERCA2a, which regulates calcium cycling and contractility in heart muscle cells. Celladon’s first product candidate, MYDICAR®, delivers the gene for the SERCA2a enzyme and is currently being tested in Phase 1 and 2 clinical trials. Celladon is also developing traditional small molecule activators of SERCA2a for the treatment of heart failure. To learn more about Celladon, visit Celladon’s website at www.celladon.net.

Location

2223 Avenida de la Playa #206
La Jolla
California
92037
United States of America

Contact

Phone: 858.366.4288
Fax: 858.964.0974
Email: info@celladon.net


News Articles [101 Associated News Articles listed on BioPortfolio]

Early Warning News Release

TORONTO, ONTARIO -- (Marketwired) -- 02/14/17 -- As a result of an agreement effective February 13, 2017 in relation to the conversion of certain outstanding debt of The Jenex Corporation (the "Corp...

Oriola-KD Corporation's 50,375 A-shares converted into B-shares

Oriola-KD Corporation Stock Exchange Release 4 January 2017 at 9.00 a.m. Oriola-KD Corporation's 50,375 A-shares converted into B-shares In accordance with Section 3 of the Byla...

Publication schedule for Oriola-KD Corporation's financial reporting in 2017

Oriola-KD Corporation Stock Exchange Release 24 November 2016 at 1.00 p.m. Publication schedule for Oriola-KD Corporation's financial reporting in 2017 Oriola-KD Corporation will...

Oriola-KD Corporation will publish its financial statements release 1 January-31 December 2016 on Monday, 13 February 2017 at 8.30 a.m.

Oriola-KD Corporation Stock Exchange Release 25 January 2017 at 1.00 p.m. Oriola-KD Corporation will publish its financial statements release 1 January-31 December 2016 on Monday, 13 ...

193,881 Orion Corporation A shares converted into B shares

  ORION CORPORATION      STOCK EXCHANGE RELEASE 27 JANUARY 2017 at 9.10 a.m. EET               193,881 Orion Corporation A shares converted into B shares In acco...

87,000 Orion Corporation A shares converted into B shares

ORION CORPORATION      STOCK EXCHANGE RELEASE 22 DECEMBER 2016 at 9.00 a.m. EET               87,000 Orion Corporation A shares converted into B shares In accor...

Repligen Acquires TangenX Technology Corporation

WALTHAM, Mass., Dec. 15, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired ...

UPDATE -- Repligen Acquires TangenX Technology Corporation

WALTHAM, Mass., Dec. 15, 2016 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [169 Associated Companies listed on BioPortfolio]

Celladon Corp.

Celladon Corp., based in La Jolla, Calif., was launched in October 2004 as a privately held biotechnology company with the goal of becoming the leader in developing molecular therapies for the treatme...

Celladon Corporation

Celladon Corporation, based in La Jolla, California, was launched in October 2004 as a privately held biotechnology company founded with the goal of becoming the leader in develop...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

NEC Corporation of America

NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...

More Information about "Celladon Corporation" on BioPortfolio

We have published hundreds of Celladon Corporation news stories on BioPortfolio along with dozens of Celladon Corporation Clinical Trials and PubMed Articles about Celladon Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Celladon Corporation Companies in our database. You can also find out about relevant Celladon Corporation Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Enzymes
Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...


Corporate Database Quicklinks



Searches Linking to this Company Record